| Product Code: ETC11246094 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Unresectable Hepatocellular Carcinoma Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, 2021 & 2031F |
3.3 India Unresectable Hepatocellular Carcinoma Market - Industry Life Cycle |
3.4 India Unresectable Hepatocellular Carcinoma Market - Porter's Five Forces |
3.5 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume Share, By Treatment Option, 2021 & 2031F |
3.7 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 India Unresectable Hepatocellular Carcinoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of hepatocellular carcinoma in India |
4.2.2 Advancements in diagnostic technologies and treatment options for unresectable hepatocellular carcinoma |
4.2.3 Growing awareness about the importance of early detection and treatment of liver cancer |
4.3 Market Restraints |
4.3.1 High cost of advanced treatment options for unresectable hepatocellular carcinoma |
4.3.2 Limited access to specialized healthcare facilities in certain regions of India |
4.3.3 Lack of reimbursement policies for expensive liver cancer treatments |
5 India Unresectable Hepatocellular Carcinoma Market Trends |
6 India Unresectable Hepatocellular Carcinoma Market, By Types |
6.1 India Unresectable Hepatocellular Carcinoma Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Localized, 2021 - 2031F |
6.1.4 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Metastatic, 2021 - 2031F |
6.1.5 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Advanced Stage, 2021 - 2031F |
6.1.6 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Recurrent, 2021 - 2031F |
6.1.7 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 India Unresectable Hepatocellular Carcinoma Market, By Treatment Option |
6.2.1 Overview and Analysis |
6.2.2 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.2.4 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2.5 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Palliative Care, 2021 - 2031F |
6.2.6 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.3 India Unresectable Hepatocellular Carcinoma Market, By Drug Class |
6.3.1 Overview and Analysis |
6.3.2 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.3 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Kinase Inhibitors, 2021 - 2031F |
6.3.4 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.3.5 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Cytotoxic Agents, 2021 - 2031F |
6.3.6 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Hormonal Therapy, 2021 - 2031F |
6.4 India Unresectable Hepatocellular Carcinoma Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.4.5 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 India Unresectable Hepatocellular Carcinoma Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
7 India Unresectable Hepatocellular Carcinoma Market Import-Export Trade Statistics |
7.1 India Unresectable Hepatocellular Carcinoma Market Export to Major Countries |
7.2 India Unresectable Hepatocellular Carcinoma Market Imports from Major Countries |
8 India Unresectable Hepatocellular Carcinoma Market Key Performance Indicators |
8.1 Average time from diagnosis to initiation of treatment for unresectable hepatocellular carcinoma patients in India |
8.2 Percentage of unresectable hepatocellular carcinoma patients receiving targeted therapy or immunotherapy |
8.3 Number of research and clinical trials focused on innovative treatments for unresectable hepatocellular carcinoma in India |
9 India Unresectable Hepatocellular Carcinoma Market - Opportunity Assessment |
9.1 India Unresectable Hepatocellular Carcinoma Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Unresectable Hepatocellular Carcinoma Market Opportunity Assessment, By Treatment Option, 2021 & 2031F |
9.3 India Unresectable Hepatocellular Carcinoma Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.4 India Unresectable Hepatocellular Carcinoma Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 India Unresectable Hepatocellular Carcinoma Market - Competitive Landscape |
10.1 India Unresectable Hepatocellular Carcinoma Market Revenue Share, By Companies, 2024 |
10.2 India Unresectable Hepatocellular Carcinoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here